Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Cheston Larson

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
San Diego
Active in the record
2020 to 2026

Deal experience

Deal types
Capital Markets & IPODebt Capital MarketsM&AVenture Capital & Growth
Sectors
Consumer & RetailFinancial ServicesHealthcare & Life Sciences
Jurisdictions
European UnionNasdaqSingaporeUnited States

Recent deals

25 announced deals in the record
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 141m Lead Capital Markets San Diego
Latham Advises Crystalys Therapeutics on US$130 Million Series B Financing 23 Jul 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 130m Lead corporate San Diego
Latham & Watkins Advises Erasca on US$550 Million Upsized Public Offering of Common Stock 15 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 550m Lead corporate San Diego
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio 24 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 230m Lead corporate
Latham Advises Mineralys Therapeutics in Unique Three-Pronged Transaction — Royalty Repurchase, Debt Financing, and Equity Offering — Totaling Up to US$950 Million 8 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 950m Lead equity offering
Latham & Watkins Advises Jade Biosciences on US$45 Million Private Placement 16 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 45m Lead corporate San Diego
Latham & Watkins Advises on Halozyme Therapeutics’ Convertible Senior Notes Offerings Totaling US$1.3 Billion 8 Nov 2025
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 1.30bn corporate
Latham & Watkins Advises Callio Therapeutics on US$187 Million Series A Financing and Concurrent Exclusive License From Hummingbird Bioscience 5 Mar 2025
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLPLatham & Watkins LLP USD 187m Lead corporate San Diego
Latham & Watkins Advises on CG Oncology’s Public Offering 14 Dec 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 204m Lead capital markets San Diego
Latham Advises Phathom Pharmaceuticals on US$130 Million Offering of Common Stock and Pre-Funded Warrants 20 Aug 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 130m Lead corporate San Diego
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Cheston Larson is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 25 deals for Cheston Larson

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction